Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop

Autor:	Ronald A Salerno, Lawrence J. Lesko
Rok vydání:	2006
Předmět:	Genetic Markers Pharmacology medicine.medical_specialty Drug Industry United States Food and Drug Administration business.industry MEDLINE Risk Assessment United States Pharmacogenetics Drug Design Pharmacogenomics Genetics Molecular Medicine Medicine Medical physics business Risk assessment
Zdroj:	The Pharmacogenomics Journal. 6:78-81
ISSN:	1473-1150 1470-269X
DOI:	10.1038/sj.tpj.6500345
Popis:	Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::751b755f5d1e942dfdece699d0e3fb39 https://doi.org/10.1038/sj.tpj.6500345 Zobrazit plný text záznamu Plný text ve formátu PDF